Quantitation of ergosterol content: Novel method for determination of fluconazole susceptibility of Candida albicans

Journal of Clinical Microbiology

Volumn 37, Issue 10, 1999, Pages 3332-3337

  Arthington Skaggs, Beth A ^b   Jradi, Hoda ^b   Desai, Tejal ^b   Morrison, Christine J ^a,b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ERGOSTEROL; FLUCONAZOLE;

ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; MINIMUM INHIBITORY CONCENTRATION; MYCOSIS; NONHUMAN; PRIORITY JOURNAL; SPECTROPHOTOMETRY;

CANDIDA ALBICANS;

EID: 0032859276     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.37.10.3332-3337.1999     Document Type: Article

References (33)

1. Arikan, S., D. Gur, and M. Akova. 1997. Comparison of E-test, microdilution and colorimetric dilution with reference broth macrodilution method for antifungal susceptibility testing of clinically significant Candida species isolated from immunocompromised patients. Mycoses 40:291-296.
2. Arthington-Skaggs, B. A., H. Jradi, T. Desai, E. Latimer, and C. J. Morrison. 1998. Determination of azole susceptibility by quantitation of ergosterol content, abstr. C-284, p. 178. In Program and abstracts of the 98th General Meeting of the American Society for Microbiology. American Society for Microbiology, Washington, D.C.
3. Arthington-Skaggs, B. A., M. Motley, E. Reiss, and C. J. Morrison. 1997. Evaluation of a commercially prepared microdilution panel for antifungal susceptibility testing, abstr. P509, p. 206. In Program and abstracts of the 13th Congress of the International Society for Human and Animal Mycology.
4. Arthington-Skaggs, B. A., and C. J. Morrison. 1999. Validation of the sterol quantitation method as a tool to predict in vivo response to fluconazole in experimental murine candidiasis. In Program and abstracts of the 5th Candida and Candidiasis Conference. American Society for Microbiology, Washington, D.C.
5. Barchiesi, F., M. D. Poeta, V. Morbiducci, F. Ancarani, and G. Scalise. 1993. Turbidimetric and visual criteria for determining the in vitro activity of six antifungal agents against Candida spp. and Cryptococcus neoformans. Mycopathologia 124:19-25.
6. Bard, M., N. D. Lees, L. S. Burrows, and F. W. Kleinhans. 1978. Differences in crystal violet uptake and cation-induced death among yeast sterol mutants. J. Bacteriol. 135:1146-1148.
7. Breivik, O. N., and J. L. Owades. 1957. Spectrophotometric semi-microdetermination of ergosterol in yeast. Agric. Food Chem. 5:360-363.
8. Davey, K. G., A. Szekely, E. M. Johnson, and D. W. Warnock. 1998. Comparison of a new commercial colorimetric microdilution method with a standard method for in-vitro susceptibility testing of Candida spp. and Cryptococcus neoformans. J. Antimicrob. Chemother. 42:439-444.
9. Espinel-Ingroff, A., J. L. Rodriguez-Tudela, and J. V. Martinez-Suarez. 1995. Comparison of two alternative microdilution procedures with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro testing of fluconazole-resistant and -susceptible isolates of Candida albicans. J. Clin. Microbiol. 33:3154-3158.
10. Espinel-Ingroff, A., M. S. Barlett, R. Bowden, N. X. Chin, J. C. R. Cooper, A. Fothergill, M. R. McGinnis, P. Menezes, S. A. Messer, P. W. Nelson, F. C. Odds, L. Pasarell, J. Peter, M. A. Pfaller, J. H. Rex, M. G. Rinaldi, G. S. Shankland, T. J. Walsh, and I. Weitzman. 1997. Multicenter evaluation of proposed standardized procedures for antifungal susceptibility testing of filamentous fungi. J. Clin. Microbiol. 35:139-143.
11. Geber, A., C. A. Hitchcock, J. E. Swartz, F. S. Pullen, K. E. Marsden, K. J. Kwon-Chung, and J. E. Bennett. 1995. Deletion of the Candida glabrata ERG3 and ERG11 genes: effect on cell viability, cell growth, sterol composition, and antifungal susceptibility. Antimicrob. Agents Chemother. 39: 2708-2727.
12. Kelly, S. L., D. C. Lamb, A. J. Corran, B. C. Baldwin, and D. E. Kelly. 1995. Mode of action and resistance to azole antifungals associated with the formation of 14α-methylergosta-8,24(28)-dien-3β,6α-diol. Biochem. Biophys. Res. Commun. 207:910-915.
13. Kelly, S. L., D. C. Lamb, D. E. Kelly, N. J. Manning, J. Loeffler, H. Hebart, U. Schunacher, and E. Einsele. 1997. Resistance to fluconazole and cross-resistance to amphotericin B in Candida albicans from AIDS patients caused by defective sterol delta 5,6-desaturation. FEBS Lett. 400:80-82.
14. Lamb, D. C., D. E. Kelly, W. H. Schunck, A. Z. Shyadehi, M. Akhtar, D. J. Lowe, B. C. Baldwin, and S. L. Kelly. 1997. The mutation T315A in Candida albicans sterol 14 alpha-demethylase causes reduced enzyme activity and fluconazole resistance. J. Biol. Chem. 272:5682-5688.
15. Makimura, K., T. Sudo, M. Kudo, K. Uchida, and H. Yamaguchi. 1998. Development of reference procedures for broth microdilution antifungal susceptibility testing of yeasts with standardized endpoint determination. Microbiol. Immunol. 42:55-59.
16. National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard. Document M27-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
17. Parkinson, T., D. J. Falconer, and C. A. Hitchcock. 1995. Fluconazole resistance due to energy-dependent drug efflux in Candida glabrata. Antimicrob. Agents Chemother. 39:1695-1699.
18. Pfaller, M. A., B. Buschelman, M. J. Bale, M. Lancaster, A. Espinel-Ingroff, J. H. Rex, and M. G. Rinaldi. 1994. Multicenter comparison of a colorimetric microdilution broth method with the reference macrodilution method for in vitro susceptibility testing of yeast isolates. Mycology 19:9-15.
19. Pfaller, M. A., and M. G. Rinaldi. 1993. Antifungal susceptibility testing: current state of technology, limitations, and standardization. Infect. Dis. Clin. N. Am. 7:435-444.
20. Pfaller, M. A., M. G. Rinaldi, J. N. Galgiani, M. S. Bartlett, B. A. Body, A. Espinel-Ingroff, R. A. Fromtling, G. S. Hall, C. E. Hughes, F. C. Odds, and A. M. Sugar. 1990. Collaborative investigation of variables in susceptibility testing of yeasts. Antimicrob. Agents Chemother. 34:1648-1654.
21. Ramani, R., A. Ramani, and S. J. Wong. 1997. Rapid flow cytometric susceptibility testing of Candida albicans. J. Clin. Microbiol. 35:2320-2324.
22. Rees, J. R., R. W. Pinner, R. A. Hajjeh, M. E. Brandt, and A. L. Reingold. 1998. The epidemiological features of invasive mycotic infections in the San Francisco Bay area, 1992-1993: results of population-based laboratory active surveillance. Clin. Infect. Dis. 27:1138-1147.
23. Revankar, S. G., W. R. Kirkpatrick, R. K. McAtee, A. W. Fothergill, S. W. Redding, M. G. Rinaldi, and T. F. Patterson. 1998. Interpretation of trailing endpoints in antifungal susceptibility testing by the National Committee for Clinical Laboratory Standards method. J. Clin. Microbiol. 36:153-156.
24. Rex, J. H., M. A. Pfaller, J. N. Galgiani, M. S. Bartlett, A. Espinel-Ingroff, M. A. Ghannoum, M. L. Lancaster, F. C. Odds, M. G. Rinaldi, T. J. Walsh, and A. L. Barry. 1997. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and Candida infections. Clin. Infect. Dis. 24:235-247.
25. Rex, J. H., P. W. Nelson, V. L. Paetznlck, M. Lozano-Chiu, and A. Espind-Ingroff. 1998. Optimizing the correlation between results of testing in vitro and therapeutic outcome in vivo for fluconazole by testing clinical isolates in a murine model of invasive candidiasis. Antimicrob. Agents Chemother. 42:129-134.
26. Rodriguez, R. J., C. Low, C. D. K. Bottema, and L. W. Parks. 1985. Multiple functions for sterols in Saccharomyces cerevisiae. Biochem. Biophys. Res. Commun. 112:47-54.
27. Rodriguez-Tudela, J. L., J. Berenguer, J. V. Martinez-Suarez, and R. Sanchez. 1996. Comparison of a spectrophotometric microdilution method with RPMI-2% glucose with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro susceptibility testing of amphotericin B, flucytosine, and fluconazole against Candida albicans. Antimicrob. Agents Chemother. 40:1998-2003.
28. Sanglard, D., F. Ischer, L. Koymans, and J. Bille. 1998. Amino acid substitutions in the cytochrome P-450 lanosterol 14 alpha-demethylase (CYP51A1) from azole-resistant Candida albicans isolates contribute to resistance to azole antifungal agents. Antimicrob. Agents Chemother. 42:241-253.
29. Sanglard, D., K. Kuchler, F. Ischer, J.-L. Pagani, M. Monod, and J. Bille. 1995. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob. Agents Chemother. 39:2378-2386.
30. Vanden Bossche, H. V., F. Dromer, I. Improvisi, M. Lozano-Chiu, J. H. Rex, and D. Sanglard. 1998. Antifungal drug resistance in pathogenic fungi. Med. Mycol. 36(Suppl. 1):119-121.
31. Wanger, A., K. Mills, P. W. Nelson, and J. H. Rex. 1995. Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistant Candida isolates. Antimicrob. Agents Chemother. 39:2520-2522.
32. Wenisch, C., K. F. Linnau, B. Parschalk, K. Zedtwitz-Liebenstein, and A. Georgopoulos. 1997. Rapid susceptibility testing of fungi by flow cytometry using vital staining. J. Clin. Microbiol. 35:5-10.
33. White, T. C. 1997. The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14 alpha-demethylase in Candida albicans. Antimicrob. Agents Chemother. 41:1488-1494.